A retrospective analysis of first-line PD-1 monoclonal antibodies treatment in patients with leptomeningeal metastasis from solid tumors.

Zhaohui Chu,Hao Lin,Qiong Zhan,Tao Liu,Yu Wang

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners（2023）

引用 0|浏览9

暂无评分

摘要

Patients with LM from ST can benefit from first-line PD-1 mAb combined treatment without additional neurotoxicity. Further research is required to validate the safety and efficacy.

查看译文

关键词

Leptomeningeal metastasis,PD-1 monoclonal antibody,first-line treatment,solid tumor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要